Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age - Top-Institutions - MDSpire

Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age

  • By

  • Christina A Rostad

  • James D Campbell

  • Grant C Paulsen

  • Sabine Schnyder Ghamloush

  • Wenqin Xu

  • Lingyi Zheng

  • M Juliana McElrath

  • Stephen C De Rosa

  • Bethany Girard

  • Rituparna Das

  • Evan J Anderson

  • C Buddy Creech

  • on behalf of the KidCOVE CMI Study Group

  • March 22, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Pediatric Vaccine Research

  • #2

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Infectious Diseases
    • Immunology
    • Vaccine Research

  • #3

    Vaccine Research Center (VRC), NIAID, NIH
    Vaccine Research Center (VRC), NIAID, NIH

    Bethesda, MD

    Key Differentiators

    • Vaccine Development
    • Immunology
    • Infectious Diseases

  • #4

    Massachusetts General Hospital (MGH) - Center for Vaccine Research
    Massachusetts General Hospital (MGH) - Center for Vaccine Research

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Pediatric Research

  • #5

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Immunology
    • Pediatric Infectious Diseases
    • Vaccine Research

Original Source(s)

Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age

  • by Christina A Rostad, James D Campbell, Grant C Paulsen, Sabine Schnyder Ghamloush, Wenqin Xu, Lingyi Zheng, M Juliana McElrath, Stephen C De Rosa, Bethany Girard, Rituparna Das, Evan J Anderson, C Buddy Creech, on behalf of the KidCOVE CMI Study Group

  • March 22, 2025

Related Content

MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection

Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy

Medical Oddities: Can a Home Be Preventive Care?

This week’s medical plot twists involved ants, architecture, and auditory hallucinations.